5.07
0.02 (0.4%)
0.02 (0.4%)
Upgrade to Real-Time
Afterhours (Closed)
Low
4.30
High
12.00
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Orgenesis Inc | ORGS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.02 | 0.4% | 5.07 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.09 | 5.01 | 5.20 | 5.07 | 5.05 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.97 | 8.75 | 3.78 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 874 | 68,210 | $ 5.09 | $ 347,018 | 166,119 | 4.30 - 12.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:16:44 | 15 | $ 5.07 | USD |
Orgenesis Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 112.02M | 22.09M | 12.75M | $ 33.26M | $ - | -1.62 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Orgenesis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ORGS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.23 | 5.5489 | 5.01 | 5.19 | 79,396 | -0.16 | -3.06% |
| 1 Month | 6.98 | 7.08 | 5.01 | 5.60 | 113,470 | -1.91 | -27.36% |
| 3 Months | 6.70 | 8.30 | 5.01 | 6.80 | 152,760 | -1.63 | -24.33% |
| 6 Months | 5.06 | 8.30 | 4.30 | 6.22 | 121,053 | 0.01 | 0.2% |
| 1 Year | 4.80 | 12.00 | 4.30 | 6.23 | 116,549 | 0.27 | 5.63% |
| 3 Years | 10.50 | 12.00 | 2.35 | 5.86 | 67,161 | -5.43 | -51.71% |
| 5 Years | 9.45 | 16.80 | 2.35 | 6.13 | 67,608 | -4.38 | -46.35% |
Orgenesis Description
| Orgenesis Inc is a part of the healthcare sector. It is a fully-integrated biopharmaceutical company focused on developing trans-differentiation technologies for diabetes and vertically integrating manufacturing that can optimize its abilities to scale-up its technologies for clinical trials and eventual commercialization. The group operates in two segments namely CDMO and POC. The company is also engaged in applying its disciplined execution to emerging technologies of other cell therapy markets in such areas as cell-based cancer immunotherapies and neurodegenerative diseases. |
